To the content
4 . 2019

Lipoic acid: physiological role and prospects for clinical application

Keywords:lipoic acid, antioxidants, obesity, diabetes mellitus, impaired glucose tolerance, diabetic polyneuropathy

For citation: Tutelyan V.A., Makhova A. A., Pogozheva A.V., Shikh E.V., Elizarova E.V., Khotimchenko S.A. Lipoic acid: physiological role and prospects for clinical application. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (4): 6-11. doi: 10.24411/0042-8833-2019-10035 (in Russian)

References

1. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., Hagen T.M. 16. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem. 2004; 11 (9): 1135-46.

2. Mayr J.A., Feichtinger R.G., Tort F., Ribes A., Sperl W. Lipoic acid biosynthesis defects. J Inherit Metab Dis. 2014; 37 (4): 553-63.

3. Gleiter C.H., Schug B.S., Hermann R., Elze M., Blume H.H., 17. Gundert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol. 1996; 50 (6): 513-4.

4. Suh J.H., Moreau R., Heath S.H., Hagen T.M. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 2005; 10 (1): 52-60.

5. Rooney J.P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology. 2007; 234 (3): 145-56.

6. Zhang J., Zhou X., Wu W., Wang J., Xie H., Wu Z. Regeneration of glutathione by alpha-lipoic acid via Nrf2/ARE signaling pathway alleviates cadmium-induced HepG2 cell toxicity. Environ Toxicol Pharmacol. 2017; 51: 30-7.

7. Fratantonio D., Speciale A., Molonia M.S., et al. Alpha-lipoic acid, but not di-hydrolipoic acid, activates Nrf2 response in primary human umbilical-vein endothelial cells and protects against TNF-alpha induced endothelium dysfunction. Arch Biochem Biophys. 2018; 655: 18-25.

8. Sena C.M., Cipriano M.A., Botelho M.F., Seica R.M. Lipoic acid prevents high-fat diet-induced hepatic steatosis in Goto Kakizaki rats by reducing oxidative stress through Nrf2 activation. Int J Mol Sci. 2018; 19 (9).

9. Fayez A.M., Zakaria S., Moustafa D. Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats. Biomed Pharmacother. 2018; 105: 428-33.

10. Dong Y., Wang H., Chen Z. Alpha-lipoic acid attenuates cerebral ischemia and reperfusion injury via insulin receptor and PI3K/ Akt-dependent inhibition of NADPH oxidase. Int J Endocrinol. 2015; 2015: 903186.

11. Byun E., Lim J.W., Kim J.M., Kim H. alpha-Lipoic acid inhibits Helicobacter pylori-induced oncogene expression and hyperproliferation by suppressing the activation of NADPH oxidase in gastric epithelial cells. Mediators Inflamm. 2014; 2014: 380830.

12. Diesel B., Kulhanek-Heinze S., Holtje M., et al. Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. Biochemistry. 2007; 46 (8): 2146-55.

13. Ying Z., Kampfrath T., Sun Q., Parthasarathy S., Rajagopalan S. Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function. Inflamm Res. 2011; 60 (3): 219-25.

14. Wang Y., Li X., Guo Y., Chan L., Guan X. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism. 2010; 59 (7): 967-76.

15. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol. 2004; 3 (3): 173-89.

16. Akbari M., Ostadmohammadi V., Lankarani K.B., et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018; 87: 56-69.

17. Heinisch B.B., Francesconi M., Mittermayer F., et al. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Eur J Clin Invest. 2010; 40 (2): 148-54.

18. Xiang G., Pu J., Yue L., Hou J., Sun H. alpha-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose. Metabolism. 2011; 60 (4): 480-5.

19. Han T., Bai J., Liu W., Hu Y. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012; 167 (4): 465-71.

20. Ziegler D., Low P.A., Freeman R., Tritschler H., Vinik A.I. Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial. J Diabetes Complications. 2016; 30 (2): 350-6.

21. URL: https://www.rmj.ru/articles/nevrologiya/Mesto_vitaminov_ gruppy_V_i_lipoevoy_kisloty_v_farmakoterapii_polineyropatiy/ (2015)

22. Salinthone S., Schillace R.V., Tsang C., Regan J.W., Bourdette D.N., Carr D.W. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. J Nutr Biochem. 2011; 22 (7): 681-90.

23. Khalili M., Azimi A., Izadi V., et al. Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a doubleblind, placebo-controlled, randomized clinical trial. Neuroimmu-nomodulation. 2014; 21 (6): 291-6.

24. National Multiple Sclerosis Society. Definition of Multiple Sclerosis (MS). URL: https://www.nationalmssociety.org/What-is-MS/ Definition-of-MS. (date of access September 28, 2018)

25. Molz P., Schroder N. Potential therapeutic effects of lipoic acid on memory deficits related to aging and neurodegeneration. Front Pharmacol. 2017; 8: 849.

26. Hager K., Kenklies M., McAfoose J., Engel J., Munch G. Alpha-lipoic acid as a new treatment option for Alzheimer’s disease -a 48 months follow-up analysis. J Neural Transm Suppl. 2007; 72: 189-93.

27. Shinto L., Quinn J., Montine T., et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J. Alzheimers Dis. 2014; 38 (1): 111-20.

28. Namazi N., Larij ani B., Azadbakht L. Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials. Clin Nutr. 2018; 37 (2): 419-28.

29. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009; 1790 (10): 1149-60.

30. Karaarslan U., Isguder R., Bag O., Kisla M., Agin H., Unal N. Alpha lipoic acid intoxication, treatment and outcome. Clin Toxicol (Phila). 2013; 51 (6): 522.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»